On Tuesday, Piper Sandler updated its financial model for Westlake Chemical (NYSE: NYSE:WLK), resulting in a raised stock price target to $180 from the previous $160, while keeping an Overweight rating on the stock. The firm's adjustments reflect the latest quarterly earnings and guidance, alongside recent market evaluations.
The revision of Westlake Chemical's price target comes after considering the first quarter of 2024 earnings release and the second quarter guidance, along with insights from recent channel checks. Despite reducing the EBITDA estimates for 2024 and 2025, Piper Sandler's projections remain significantly higher than the street consensus for both years.
The analyst pointed out that the adjustments in earnings expectations are mainly due to a slower-than-anticipated recovery in the product margins for PVC and epoxy. This slower rebound is connected to the gradual economic recovery in Europe and Asia. Still, there is an anticipation of a pickup in the PVC markets starting in the second quarter, which is expected to build momentum through the remainder of the year and into 2025.
The recovery pace of the PVC markets is believed to be closely tied to the construction markets' resurgence. As for the epoxy markets, the analyst expects a more extended recovery period. This is because the epoxy market's rebound is dependent not only on China's capacity to absorb exported products but also on Europe's ability to consume existing capacity once the Chinese products are redirected back to the domestic market.
The new stock price target of $180 reflects Piper Sandler's confidence in Westlake Chemical's potential for growth despite the current challenges in the market. The firm anticipates that the company's financial performance will improve as the global economy, particularly the construction sector, gains strength in the coming months.
InvestingPro Insights
The latest revision by Piper Sandler comes at a time when Westlake Chemical's financial metrics show a mixed landscape. With a market capitalization of $19.71 billion and a P/E ratio that has adjusted to 34.29 from a high 76.05, investors are looking at a company that is revaluing its growth prospects. The PEG ratio, currently at -0.89, suggests potential undervaluation if the company can navigate the expected market recovery effectively.
Revenue contraction has been a concern, with a -19.39% change over the last twelve months as of Q1 2024, reflecting the ongoing challenges in the market. However, a strong dividend growth of 40.06% during the same period signals confidence in the company's ability to maintain shareholder value.
The recent price performance has been positive, with a 9.93% year-to-date total return, indicating a possible turnaround as the market anticipates a recovery in the construction sector that Westlake is poised to capitalize on.
InvestingPro Tips highlight the importance of monitoring the company's next earnings date on July 30, 2024, as it will provide further clarity on Westlake's performance and market trajectory. Additionally, investors are encouraged to consider the discrepancy between the analyst's target of $160 and the InvestingPro Fair Value estimate of $135.01, which may suggest a need for caution.
For more in-depth analysis and additional tips, subscribers can explore InvestingPro, and don't forget to use the promo code PRONEWS24 for an extra 10% off a yearly or biyearly Pro and Pro+ subscription. With 15 more InvestingPro Tips available, investors can gain a comprehensive understanding of Westlake Chemical's potential and position themselves accordingly.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.